APA

Steele T. M., Talbott G. C., Sam A., Tepper C. G., Ghosh P. M. & Vinall R. L. (20190716). Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. : International journal of molecular sciences.

Chicago

Steele Thomas M, Talbott George C, Sam Anhao, Tepper Clifford G, Ghosh Paramita M and Vinall Ruth L. 20190716. Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. : International journal of molecular sciences.

Harvard

Steele T. M., Talbott G. C., Sam A., Tepper C. G., Ghosh P. M. and Vinall R. L. (20190716). Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. : International journal of molecular sciences.

MLA

Steele Thomas M, Talbott George C, Sam Anhao, Tepper Clifford G, Ghosh Paramita M and Vinall Ruth L. Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. : International journal of molecular sciences. 20190716.